Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linda J Popplewell

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2012
Optimizing antisense oligonucleotides using phosphorodiamidate morpholino oligomersLinda J Popplewell, Alberto Malerba, George Dickson
Methods in Molecular Biology (Clifton, N.J.)|January 4, 2011
Bioinformatic and functional optimization of antisense phosphorodiamidate morpholino oligomers (PMOs) for therapeutic modulation of RNA splicing in muscleLinda J Popplewell, Ian R Graham, Alberto Malerba, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 15, 2009
Design of phosphorodiamidate morpholino oligomers (PMOs) for the induction of exon skipping of the human DMD geneLinda J Popplewell, Capucine Trollet, George Dickson, et al.
Biomedicines|June 27, 2018
Targeting TGFβ Signaling to Address Fibrosis Using Antisense OligonucleotidesJames T March, Golnoush Golshirazi, Viktorija Cernisova, et al.
Nucleic Acid Therapeutics|June 3, 2021
Knockdown of Muscle-Specific Ribosomal Protein L3-Like Enhances Muscle Function in Healthy and Dystrophic MiceBetty R Kao, Alberto Malerba, Ngoc B Lu-Nguyen, et al.
Neuromuscular Disorders : NMD|January 19, 2010
Comparative analysis of antisense oligonucleotide sequences targeting exon 53 of the human DMD gene: Implications for future clinical trialsLinda J Popplewell, Carl Adkin, Virginia Arechavala-Gomeza, et al.
Molecules (Basel, Switzerland)|January 26, 2012
Novel cationic carotenoid lipids as delivery vectors of antisense oligonucleotides for exon skipping in Duchenne muscular dystrophyLinda J Popplewell, Aseel Abu-Dayya, Tushar Khanna, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2012
Optimizing antisense oligonucleotides using phosphorodiamidate morpholino oligomersLinda J Popplewell, Alberto Malerba, George Dickson
Methods in Molecular Biology (Clifton, N.J.)|January 4, 2011
Bioinformatic and functional optimization of antisense phosphorodiamidate morpholino oligomers (PMOs) for therapeutic modulation of RNA splicing in muscleLinda J Popplewell, Ian R Graham, Alberto Malerba, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 15, 2009
Design of phosphorodiamidate morpholino oligomers (PMOs) for the induction of exon skipping of the human DMD geneLinda J Popplewell, Capucine Trollet, George Dickson, et al.
Biomedicines|June 27, 2018
Targeting TGFβ Signaling to Address Fibrosis Using Antisense OligonucleotidesJames T March, Golnoush Golshirazi, Viktorija Cernisova, et al.
Nucleic Acid Therapeutics|June 3, 2021
Knockdown of Muscle-Specific Ribosomal Protein L3-Like Enhances Muscle Function in Healthy and Dystrophic MiceBetty R Kao, Alberto Malerba, Ngoc B Lu-Nguyen, et al.
Neuromuscular Disorders : NMD|January 19, 2010
Comparative analysis of antisense oligonucleotide sequences targeting exon 53 of the human DMD gene: Implications for future clinical trialsLinda J Popplewell, Carl Adkin, Virginia Arechavala-Gomeza, et al.
Molecules (Basel, Switzerland)|January 26, 2012
Novel cationic carotenoid lipids as delivery vectors of antisense oligonucleotides for exon skipping in Duchenne muscular dystrophyLinda J Popplewell, Aseel Abu-Dayya, Tushar Khanna, et al.
Pageof 1